3D Bioprinted Neural‐Like Tissue as a Platform to Study Neurotropism of Mouse‐Adapted SARS‐CoV‐2-Reference-Cited by-同舟云学术

3D Bioprinted Neural‐Like Tissue as a Platform to Study Neurotropism of Mouse‐Adapted SARS‐CoV‐2

Published:2022-05-06 Issue:8 Volume:6 Page:2200002
ISSN:2701-0198
Container-title:Advanced Biology
language:en
Short-container-title:Advanced Biology

Author:

de Melo Bruna A. G.¹,Mundim Mayara V.¹,Lemes Robertha M. R.²,Cruz Elisa M.¹,Ribeiro Tais N.¹,Santiago Carolina F.³,da Fonsêca Jéssica H. L.⁴,Benincasa Julia C.¹,Stilhano Roberta S.⁵,Mantovani Nathalia⁶,Santana Luiz C.⁶,Durães‐Carvalho Ricardo³,Diaz Ricardo S.⁶,Janini Luiz M. R.³,Maricato Juliana T.³,Porcionatto Marimelia A.¹^ORCID

Affiliation:

1. Department of Biochemistry Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo 04039‐032 Brazil

2. Department of Biological Sciences Universidade Federal de São Paulo Diadema 09920‐540 Brazil

3. Department of Microbiology Immunology and Parasitoloy Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo 04039‐032 Brazil

4. Department of Manufacturing and Materials Engineering Faculdade de Engenharia Mecânica Universidade Estadual de Campinas Campinas SP 13083‐860 Brazil

5. Department of Physiological Sciences Faculdade de Ciências Médicas Santa Casa de São Paulo São Paulo 01221‐020 Brazil

6. Department of Medicine Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo 04039‐032 Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adbi.202200002

Reference103 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2. Recent advances in vaccine and immunotherapy for COVID-19

3. World Health Organization Coronavirus disease (COVID‐ 19) pandemic https://covid19.who.int/(accessed: April2022).

4. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

5. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rising role of 3D-printing in delivery of therapeutics for infectious disease;Journal of Controlled Release;2024-02

2. Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics;Frontiers in Materials;2022-11-24